Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422485 · ClinicalTrials.gov registry record · Phase 1
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
A Phase 1 study, sponsored by Adam Boxer.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT02422485 is a Phase 1 study that has completed, run by Adam Boxer. The registered enrollment target is 10 participants.
The verdict
NCT02422485, a Phase 1 study, has completed, sponsored by Adam Boxer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a multi-center, open label, pilot futility clinical trial of the safety, tolerability, pharmacodynamics and preliminary efficacy of oral salsalate in up to 10 patients with PSP.
Interventions
- DRUG Salsalate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-04 |
| Est. Completion | 2019-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02422485
The ClinicalTrials.gov registry entry for NCT02422485 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Adam Boxer, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Salsalate is the first listed.
NCT02422485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02422485 about?
NCT02422485 is a clinical study titled "A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy". This is a multi-center, open label, pilot futility clinical trial of the safety, tolerability, pharmacodynamics and preliminary efficacy of oral salsalate in up to 10 patients with PSP.
What is the current status of trial NCT02422485?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2015-04. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02422485?
The interventions under investigation include: Salsalate (DRUG).
Who is sponsoring clinical trial NCT02422485?
This trial is sponsored by Adam Boxer, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.